| Pharmaceutical active ingredients: |
| Interferon Alfa-2c |
| Available forms, composition and doses of Berofor Injections: |
| Injectable; Injection; Interferon Alfa-2c |
| Berofor Injections medical category: |
| Human:Antineoplastic agentsAntiviralsImmunological chemotherapyInterferons |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L03AB - Interferons |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Boehringer Ingelheim |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Intron A / Rebetol | Interferon Alfa-2b; Ribavirin | Schering-Plough; Essex |
| Rebetron | Interferon Alfa-2b; Ribavirin | Schering-Plough; Bayer Schering Pharma; Essex |
| Rebetron Combination Therapy | Interferon Alfa-2b; Ribavirin | Schering-Plough; Bayer Schering Pharma |
| Berofor | Interferon Alfa-2c | Boehringer Ingelheim; Galderma |
| Berofor Eye Drops | Interferon Alfa-2c | Boehringer Ingelheim |
| Inferax | Interferon Alfacon-1 | Yamanouchi |
| Infergen | Interferon Alfacon-1 | Intermune Pharmaceuticals; Amgen; Astellas Pharma; Chiesi; Cobalt Pharmaceuticals; Gerolymatos; Pharma-Regist; Three Rivers Pharmaceuticals; Yamanouchi |
| Humoferon | Interferon Alfa-n1 | Sigma-Tau Pharmaceuticals |
| Wellferon | Interferon Alfa-n1 | GlaxoSmithKline; The Wellcome Foundation |
| Alferon N | Interferon Alfa-n3 | Interferon Sciences; HemispheRx |